Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Inocras

Inocras Inc. offers whole genome sequencing for personalized care in cancer and rare diseases, using AI.
2020
51-100
San Diego, California, United States
AnalyticsBiotechnologynologyGeneticsMedicalPrecision MedicineTest and Measurement

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

52.7M

Last Funding Date

05-12-2024

Lead Investors

InterVest Co., DSC Investment, Schmidt, Samsung Venture Investment, Ministry of SMEs and Startups

Revenue

$1M to $10M

People

Founders